Global In-Vitro Diagnostics market is expected to grow at a CAGR of 4.8% during 2021-2026

DELTA, British Columbia - April 2, 2021 - PRLog -- The growth of the Global In-Vitro Diagnostics Market is attributed to the rising demand for advanced diagnostic solutions and the adoption of advanced technologies by the healthcare industry. Besides this, the high demand for personalized medicine and treatment through early diagnosis that helps in reducing the overall cost of treatment is propelling the growth of the In-Vitro Diagnostics Market across the world.

According to the MarkNtel Advisors' research report, "Global In-Vitro Diagnostics Market Analysis, 2021", the Market is expected to grow at a CAGR of 4.8% during 2021-26.

Immunoassays Segment Holds the Largest Market Share

Based on Technique, the immunoassays segment has dominated the Global In-Vitro Diagnostics Market in 2019. The growth of this segment is due to high usage rate of immunoassays technique for the detection of infectious microbes such as fungus, virus, and bacteria. In addition to this, rise in the occurrence of chronic diseases such as HIV entwined with availability of instruments with higher accuracy is providing a lucrative opportunity to drive the growth of the market in the forthcoming timeline.

"Global In-Vitro Diagnostics Market Analysis, 2021" provides comprehensive qualitative and quantitative insights on the market potential, key factors impacting the market growth, hotspots and opportunities available for In-Vitro Diagnostics providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.

Point of Care Testing Exhibits Fastest Growth

Snowballing demand for point-of-care devices is anticipated to catalyze the growth of the In-Vitro Diagnostics market during 2021-26. Along with this, the surge in adoption of high-end technologies such as Nano-biotechnology that helps in offering quick and accurate test results is likely to boost the demand for in-vitro diagnostic devices. Thereby, this is projected to contribute to the growth of the global In-Vitro Diagnostics market in the forecast period as revealed by MarkNtel Advisors' research report "Global In-Vitro Diagnostics Market Analysis, 2021".

Get the sample copy of the market study: https://www.marknteladvisors.com/query/request-sample/global-in-vitro-diagnostics-market.html

According to MarkNtel Advisors, the major leading players in the global In-Vitro Diagnostics market are BioMerieux SA, Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Siemens Healthineers AG, Qiagen, Quidel Corporation, F. Hoffmann-La Roche AG, Sysmex Corporation, Danaher Corporation, etc.